Ultrasound and Tumor Response in Colorectal Liver Metastases
Part of Cancer, Digestive system clinical trials.
This study is testing a new way to use ultrasound to help treat colorectal cancer that has spread to the liver. It may help doctors see how tumors respond to treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have colorectal cancer that has spread to your liver.
- You are scheduled for liver surgery or ablation, or you are receiving cancer treatment for liver metastases.
- You have not had chemotherapy or other cancer therapy in the last 2 weeks.
- You have never been treated with an immunotherapy drug (like Keytruda or Opdivo).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special 3D ultrasound scan (using contrast) can help support decisions for people with colorectal cancer that has spread to the liver. If you have planned new cancer treatment, the scan may add information to help doctors guide care.
This study tests a new ultrasound technique to predict whether chemotherapy will work on colorectal cancer that has spread to your liver. The technique uses sound waves and a special contrast dye to measure blood flow in tumors before treatment starts, which may help doctors know early if the treatment is working.
This study tests a tiny device that is placed in your liver tumor during surgery. It checks how well different chemotherapy drugs work on your specific cancer, which may help your doctor choose the best treatment for you.
This trial tests a combination treatment that uses heat or cold (ablation) to destroy liver tumors along with medicines that boost your immune system to fight cancer. It is for people whose colorectal cancer has spread to the liver and who could not have surgery, or whose first treatment stopped working.
This trial tests a new way to use MRI scans to better evaluate liver metastases in colorectal cancer. It may help doctors understand how tumors respond to chemotherapy.
This trial looks at whether special features seen on contrast-enhanced ultrasound can help doctors better classify liver nodules using a system called LI-RADS. It’s for people at high risk for liver cancer who have recent imaging and clear tissue diagnosis.
Hear when a new Liver Metastases From Colorectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.